We are live on ! Find out more
VANI icon

Vivani Medical
VANI

Fund managers haven’t disclosed any holdings of VANI yet.

VANI Hedge Fund Activity: Q1 2026 in Review

43 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q1 2026, worth a combined $5.61M — down 18% from $6.84M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new VANI positions and 5 closed out — a net gain of 9 holders — while 6 added to existing stakes and 9 trimmed.

The largest buyer was UBS Group, adding an estimated $414K. The largest seller was Tudor Investment Corp, cutting an estimated $613K.

  • 43 institutional investors held Vivani Medical (VANI) as of Q1 2026, up from 35 in Q4 2025.
  • Funds reported $5.61M of Vivani Medical stock for Q1 2026, down 18% quarter-over-quarter.
  • 14 funds opened new Vivani Medical positions in Q1 2026 and 5 closed out, a net change of +9 holders.
  • The largest Vivani Medical buyer in Q1 2026 was UBS Group, an estimated $414K added.
  • The largest Vivani Medical seller in Q1 2026 was Tudor Investment Corp, an estimated $613K sold.

Based on aggregated 13F filings for Q1 2026.